Antipsychotics are widely used to treat psychiatric disorders in older patients. While the growing number of second-generation antipsychotics (SGAs) has increased options for patients, it has also complicated clinical decision-making. Data from the American Psychiatric Association’s (APA’s ) Practice Research Network indicated disproportionately high use of antipsychotics and benzodiazepine medications among older patients compared with those under age 65.